Hold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial Uncertainties
Yield10 Bioscience: A Cautious Hold Amid Financial Uncertainty and Strategic Potential
Hold Recommendation on Yield10 Bioscience Amid Commercialization and Capital Uncertainties
Balancing Potential Growth With Financial Challenges: A Hold Rating for Yield10 Bioscience
Yield10 Bioscience Analyst Ratings
Yield10 Bioscience Analyst Ratings
Lake Street Sticks to Its Buy Rating for Yield10 Bioscience (YTEN)
Yield10 Bioscience Analyst Ratings
Regulatory Milestones and Commercialization Progress Drive Buy Rating for Yield10 Bioscience: An Analyst's Perspective
HC Wainwright & Co. Maintains Buy on Yield10 Bioscience, Lowers Price Target to $4
H.C. Wainwright Keeps Their Buy Rating on Yield10 Bioscience (YTEN)
Yield10 Bioscience Analyst Ratings
Lake Street Maintains Buy on Yield10 Bioscience, Lowers Price Target to $3
Yield10 Bioscience Analyst Ratings
Maxim Group Remains a Buy on Yield10 Bioscience (YTEN)
Lake Street Sticks to Its Buy Rating for Yield10 Bioscience (YTEN)
Analysts' Top Materials Picks: Hecla Mining Company (HL), Yield10 Bioscience (YTEN)
HC Wainwright & Co. Reiterates Buy on Yield10 Bioscience, Maintains $25 Price Target
Analysts Offer Insights on Materials Companies: Franco-Nevada (FNV) and Yield10 Bioscience (YTEN)
Lake Street Reaffirms Their Buy Rating on Yield10 Bioscience (YTEN)
No Data
No Data